Accipio Ax (discontinued)

MaxQ AI, Ltd.

**In January 2022 MaxQ announced the discontinuation of their imaging AI product portfolio.**
Accipio Ax™, introduces automatic slice-level annotation and prioritization of suspected ICH in CT imaging. It aids physicians in the acute care setting to interpret CT imaging and determine the presence of a suspected ICH. Accipio Ax™ can work along with Accipio Ix™ which identifies and prioritizes suspected ICH cases.
Product specifications Information source: Vendor
Last updated: Jan. 21, 2022
Product name Accipio Ax (discontinued)
Company MaxQ AI, Ltd.
Subspeciality Neuro
Modality CT
Disease targeted Intracranial hemorrhage
Key-features Slice-level detection of ICH
Suggested use
Data characteristics
Population Stroke and head trauma patients suspicious of intracranial hemorrhage.
Input Adult non-contrast head CT exams
Input format DICOM
Output Triage with notification, slice of interest
Output format DICOM Secondary Capture
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time
Certified, Class IIb , MDD
No or not yet
Market presence
On market since 12-2020
Distribution channels GE, Philips, FujiFilm, IBM, Nuance, Blackford
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers